HDL Function Panel

Your HDL cholesterol number has been called "good cholesterol" for decades. But a growing realization in cardiovascular medicine is that how much HDL you have matters far less than how well it works. Large clinical trials that raised HDL cholesterol with medications, including niacin, failed to reduce heart attacks or strokes. A large-scale genetic analysis found that inheriting genes for higher HDL cholesterol did not lower heart attack risk. The implication is clear: HDL cholesterol, the number, is not the whole story.

This panel measures the protein cargo riding on your HDL particles and uses that information to estimate how effectively your HDL performs its primary job: pulling cholesterol out of artery walls and carrying it to the liver for disposal. That process, called reverse cholesterol transport, is the reason HDL earned its "good" reputation in the first place. By measuring the specific proteins that make HDL functional (or dysfunctional), this panel gives you a window into cardiovascular protection that a standard lipid panel simply cannot provide.

Why HDL Function Matters More Than HDL Levels

The standard HDL cholesterol test on a lipid panel measures the total amount of cholesterol carried inside HDL particles. But HDL particles are not all the same. Some are efficient at extracting cholesterol from the fatty deposits in artery walls. Others are loaded with proteins that impair that ability or promote inflammation instead.

In the Dallas Heart Study, which followed 2,924 adults for a median of 9.4 years, people in the highest quarter of cholesterol efflux capacity (a measure of how well HDL removes cholesterol from cells) had a 67% lower risk of cardiovascular events compared to those in the lowest quarter. That association held even after adjusting for HDL cholesterol levels. A separate study within the EPIC-Norfolk cohort of over 3,400 participants confirmed that higher efflux capacity was associated with lower risk of coronary artery disease, with each standard deviation increase in efflux linked to roughly a 20% reduction in risk.

These findings mean two people with identical HDL cholesterol numbers can have dramatically different cardiovascular protection depending on how their HDL particles are built and what proteins they carry.

What This Panel Reveals

This panel evaluates HDL through two lenses: a set of measured proteins that sit on your HDL particles, and two calculated scores that translate those measurements into a picture of HDL function.

The first lens is the protein composition. Apolipoprotein A1 (ApoA1) is the main structural protein of HDL and the primary driver of cholesterol efflux. Higher ApoA1 generally means more functional HDL. In the INTERHEART study of over 27,000 participants across 52 countries, the ratio of ApoB (a marker of harmful particles) to ApoA1 was the strongest lipid-related predictor of heart attack, outperforming standard cholesterol measures.

The other measured proteins belong to the apolipoprotein C family. These small proteins hop between HDL and triglyceride-rich particles, and their presence on HDL can either help or hinder its function. Apolipoprotein C3 (ApoC3) has the strongest evidence base: it inhibits lipoprotein lipase, an enzyme that clears fat from the blood, and it promotes inflammation in artery walls. Two independent studies published in the New England Journal of Medicine in 2014 showed that people carrying loss-of-function mutations in the ApoC3 gene had roughly 40% lower triglycerides and approximately 40% lower risk of coronary heart disease.

Apolipoprotein C2 (ApoC2) does the opposite of ApoC3 in one key respect: it activates lipoprotein lipase and helps clear triglyceride-rich particles. Apolipoprotein C1 (ApoC1) influences how cholesterol moves between particles by inhibiting CETP, a protein that transfers cholesterol from HDL to other lipoproteins. Apolipoprotein C4 (ApoC4) is the least studied of the group but is associated with triglyceride metabolism and may influence how efficiently HDL particles are remodeled.

The second lens is the two calculated scores. The predicted cholesterol efflux capacity (pCEC) estimates how well your HDL pulls cholesterol out of cells based on the protein profile measured. The predicted coronary artery disease score (pCAD) integrates the protein data into a single probability estimate of coronary disease presence.

How to Read Your Results Together

The real value of this panel emerges when you look at the scores and individual proteins as a group. A high HDL cholesterol on your standard lipid panel paired with a low pCEC or elevated pCAD score is a red flag: your HDL looks good on paper but may not be protecting you.

Pay special attention to the ApoC3 result relative to ApoA1. When ApoC3 is disproportionately high relative to ApoA1, it suggests your HDL particles are enriched with a protein that blunts their protective function. This pattern is especially common in people with insulin resistance, metabolic syndrome (a cluster of conditions including high blood sugar, excess abdominal fat, and abnormal cholesterol), or elevated triglycerides.

When Results Can Be Misleading

Acute illness, surgery, or active infection can temporarily suppress ApoA1 and alter HDL composition, because HDL is remodeled during the inflammatory response. If you have recently been sick, results may reflect your body's short-term inflammatory reaction to illness rather than your baseline cardiovascular risk. Wait at least four to six weeks after an acute illness before testing.

Alcohol consumption affects HDL metabolism and can raise both HDL cholesterol and ApoA1 levels. Estrogen-containing medications, including oral contraceptives and hormone replacement therapy, also raise ApoA1. These influences do not necessarily mean HDL function has improved, so interpret results in the context of your medications and habits.

Extreme exercise, rapid weight loss, and very-low-fat diets can all shift HDL particle composition. If you have recently made dramatic lifestyle changes, your results may be in transition and a repeat test in three to six months will give a more stable baseline.

Tracking Over Time

A single snapshot of HDL function is useful, but serial measurements tell a richer story. If you start a Mediterranean diet, begin regular exercise, lose weight, or start a statin or fibrate (a triglyceride-lowering drug), your HDL protein composition and efflux capacity can shift over weeks to months. Repeating this panel every six to twelve months lets you see whether interventions are actually changing how your HDL works, not just how much of it you have.

Tracking ApoC3 over time is particularly valuable if you are managing insulin resistance or high triglycerides. Emerging therapies targeting ApoC3 directly are in clinical trials, and this panel could serve as a way to monitor response if those treatments become available.

What to Do with Your Results

If your pCAD score is elevated or your pCEC is low, the first step is not to panic but to contextualize. Review these results alongside your standard lipid panel, inflammatory markers like hs-CRP (high-sensitivity C-reactive protein), and metabolic markers like insulin and HbA1c (a measure of average blood sugar over three months). HDL dysfunction rarely exists in isolation; it usually travels with metabolic or inflammatory problems.

An elevated ApoC3 with high triglycerides is a pattern that responds to dietary changes (reducing refined carbohydrates and alcohol), omega-3 fatty acid supplementation, and medications like fibrates (a class of triglyceride-lowering drugs). If ApoA1 is low, weight loss, regular aerobic exercise, and moderate alcohol intake (if appropriate) are the best-studied interventions for raising it.

Consider adding an NMR Lipoprofile to see your LDL particle count and size, and a standard lipid panel if not already done. A cardiologist or lipidologist (a doctor specializing in cholesterol and lipid disorders) is the right specialist to interpret a concerning pattern on this panel, especially if your standard cholesterol numbers have been reassuring but your HDL function results suggest otherwise.